Chinook Therapeutics Inc (NASDAQ:KDNY)

18.00
Delayed Data
As of 4:00pm ET
 -0.71 / -3.79%
Today’s Change
10.48
Today|||52-Week Range
19.59
+10.36%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 31.50, with a high estimate of 48.00 and a low estimate of 28.00. The median estimate represents a +75.00% increase from the last price of 18.00.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.62
Sales
$500.0K
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.61%
 
 
 
 
 
 
Growthannually -10.05%
 
 
 
 
 
 

Sales

Growthquarterly -81.46%
 
 
 
 
 
 
Growthannually -92.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.